rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-11-18
|
pubmed:abstractText |
Chronic kidney disease is a growing public health problem that carries substantial risk for cardiovascular disease (CVD). Single studies have differentially examined the role of cystatin C, a novel renal index, with varying cut-point use. We undertook a meta-analysis of prospective studies to properly assess the link between cystatin C (dichotomized and continuous) versus CVD.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1941-7705
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
675-83
|
pubmed:dateRevised |
2011-10-27
|
pubmed:meshHeading |
pubmed-meshheading:20923994-Aged,
pubmed-meshheading:20923994-Biological Markers,
pubmed-meshheading:20923994-Coronary Disease,
pubmed-meshheading:20923994-Cystatin C,
pubmed-meshheading:20923994-Disease Progression,
pubmed-meshheading:20923994-Female,
pubmed-meshheading:20923994-Follow-Up Studies,
pubmed-meshheading:20923994-Humans,
pubmed-meshheading:20923994-Kidney Failure, Chronic,
pubmed-meshheading:20923994-Male,
pubmed-meshheading:20923994-Middle Aged,
pubmed-meshheading:20923994-Prognosis,
pubmed-meshheading:20923994-Risk,
pubmed-meshheading:20923994-Severity of Illness Index,
pubmed-meshheading:20923994-Stroke
|
pubmed:year |
2010
|
pubmed:articleTitle |
Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis.
|
pubmed:affiliation |
Stroke Center and Department of Neurology, University of California, Los Angeles, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis,
Research Support, N.I.H., Extramural
|